TriaGen Wealth Management’s Nutrien NTR Stock Holding History

TriaGen Wealth Management’s Portfolio NTR Stock Details NTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-20,287	Closed	-$2.11M	–	182
2022 Q1	$2.11M	Buy	20,287 +4,015	+25%	+$333K	1.09%	22
2021 Q4	$1.22M	Buy	+16,272	New	+$1.14M	0.6%	61

Other funds holding NTR

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

TriaGen Wealth Management's NTR Position: Q2 2022 in Review

TriaGen Wealth Management sold out of Nutrien (NTR) in Q2 2022, closing a stake of 20,287 shares — an estimated $2.11M sold.

TriaGen Wealth Management first reported a position in NTR in Q4 2021 and held it in 2 quarters. The position peaked at $2.11M in Q1 2022. 740 funds tracked by Wall St. Rank hold NTR as of Q2 2022.

TriaGen Wealth Management reported no remaining Nutrien position as of Q2 2022 after selling out during the quarter.
TriaGen Wealth Management sold 20,287 Nutrien shares in Q2 2022, an estimated $2.11M.
TriaGen Wealth Management first reported a position in Nutrien in Q4 2021 and held it in 2 quarters.
TriaGen Wealth Management's Nutrien position peaked at $2.11M in Q1 2022.
740 funds tracked by Wall St. Rank held Nutrien as of Q2 2022.

Based on TriaGen Wealth Management's 13F filing for Q2 2022, filed 29 Jul 2022.